Latin America Biological Skin Substitutes Market Size & Outlook
The biological skin substitutes market in Latin America is expected to reach a projected revenue of US$ 33.9 million by 2033. A compound annual growth rate of 8.4% is expected of Latin America biological skin substitutes market from 2026 to 2033.
Latin America biological skin substitutes market highlights
The Latin America biological skin substitutes market generated a revenue of USD 17.9 million in 2025.
The market is expected to grow at a CAGR of 8.4% from 2026 to 2033.
In terms of segment, human donor tissue-derived products was the largest revenue generating type in 2025.
Human Donor Tissue-Derived Products is the most lucrative type segment registering the fastest growth during the forecast period.
Country-wise, Brazil is expected to register the highest CAGR from 2026 to 2033.
Latin America data book summary
Market revenue in 2025
USD 17.9 million
Market revenue in 2033
USD 33.9 million
Growth rate
8.4% (CAGR from 2026 to 2033)
Largest segment
Human donor tissue-derived products
Fastest growing segment
Human Donor Tissue-Derived Products
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Acellular Animal-derived Products, Human Donor Tissue-Derived Products
Key market players worldwide
3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix
Other key industry trends
In terms of revenue, Latin America region accounted for 4.7% of the global biological skin substitutes market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 232.5 million by 2033.
Latin America is one of the fastest growing regions for the medical device outsourcing market owing to cost-effectiveness and rise in the number of new entrants venturing into the medical device market within the region. Brazil, Mexico, Colombia, Venezuela, and Argentina are driving the growth of the medical device market in Latin America.
The market is expected to showcase significant growth during the forecast period owing to increase in the number of medical device companies venturing into this region, which is anticipated to drive the demand for regulatory and quality assurance, thereby contributing to the growth of the medical device outsourcing market. In addition, its geographic placement being strategically close to the U.S. market is another factor boosting outsourcing to this region.
Presence of CROs and regulatory service providers is also expected to considerably increase, which is expected to further drive the market growth during the forecast period.
Latin America Biological Skin Substitutes Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biological Skin Substitutes Market Outlook will help companies and investors design strategic landscapes.
Human Donor Tissue-Derived Products was the largest segment with a revenue share of 73.18% in 2025.
Horizon Databook has segmented the Latin America biological skin substitutes market based on acellular animal-derived products, human donor tissue-derived products covering the revenue growth of each sub-segment from 2021 to 2033.
Latin America is one of the fastest growing regions for the medical device outsourcing market owing to cost-effectiveness and rise in the number of new entrants venturing into the medical device market within the region. Brazil, Mexico, Colombia, Venezuela, and Argentina are driving the growth of the medical device market in Latin America.
The market is expected to showcase significant growth during the forecast period owing to increase in the number of medical device companies venturing into this region, which is anticipated to drive the demand for regulatory and quality assurance, thereby contributing to the growth of the medical device outsourcing market. In addition, its geographic placement being strategically close to the U.S. market is another factor boosting outsourcing to this region.
Presence of CROs and regulatory service providers is also expected to considerably increase, which is expected to further drive the market growth during the forecast period.
Latin America Biological Skin Substitutes Market Type Outlook (Revenue, USD Million , 2021-2033)
Human Donor Tissue-Derived Products
Acellular Animal-derived Products
Latin America Biological Skin Substitutes Market Application Outlook (Revenue, USD Million , 2021-2033)
Acute wounds
Chronic wounds
Latin America Biological Skin Substitutes Market End-Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Outpatient Facilities
Research and Manufacturing
Reasons to subscribe to Biological Skin Substitutes Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biological Skin Substitutes Market Outlook databook
Our clientele includes a mix of Biological Skin Substitutes Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America Biological Skin Substitutes Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Latin America Biological Skin Substitutes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Latin America Biological Skin Substitutes Market, 2021-2033 (US$M)